Keywords:
Cancer; immune checkpoint therapy; interferon; mesothelioma; retinoic acid; gamma interferon; cell infiltration; immune response; RNA sequence; T cell lymphoma; tumor growth; tumor immunity; tumor microenvironment
Abstract:
With immune checkpoint therapy (ICT) having reshaped the treatment of many cancers, the next frontier is to identify and develop novel combination therapies to improve efficacy. Previously, we and others identified beneficial immunological effects of the vitamin A derivative tretinoin on anti-tumour immunity.